Selecta Biosciences

Cartesian Therapeutics is a clinical-stage biotechnology company focused on developing mRNA cell therapies for the treatment of autoimmune diseases. They leverage their proprietary RNA Armory® platform to create therapies designed for convenient outpatient administration without requiring preconditioning chemotherapy. Their lead asset, Descartes-08, is an autologous anti-BCMA mRNA CAR-T currently in Phase 2 trials for myasthenia gravis and systemic lupus erythematosus.

Cartesian is committed to developing next-generation cell therapies with the potential for curative effects. They operate a state-of-the-art GMP manufacturing facility, allowing them to optimize their processes while ensuring adherence to strict quality standards. Their integrated approach encompasses discovery, manufacturing, and clinical operations under one roof, fostering a collaborative and innovative environment.

Cartesian Therapeutics is a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases. Their mission is to develop safe and effective therapies with the potential to cure diseases like myasthenia gravis and systemic lupus erythematosus. They achieve this by leveraging their proprietary RNA Armory® platform to create therapies that can be administered conveniently in an outpatient setting, eliminating the need for preconditioning chemotherapy.

Cartesian Therapeutics fosters a collaborative and fast-paced environment where its world-class team of scientists are dedicated to developing cutting-edge cell therapies. The company values a highly integrated approach, with discovery, cGMP manufacturing, and clinical operations all happening under one roof. This immersive experience allows team members to learn and grow, while a sense of family is cultivated through close, cross-functional, and continuous communication with highly committed colleagues.

Cartesian Therapeutics is committed to building a diverse, equitable, and inclusive workplace. They value the unique perspectives and experiences of all team members, recognizing that a diverse workforce leads to better decision-making and innovation. Their commitment to DE&I is evident in their inclusive hiring practices, development programs that support all employees, and efforts to create a welcoming and respectful environment for everyone.